APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-dementia Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-dementia Drugs Industry Growth and Trends Forecast to 2032

27 December 2025126 pages

Choose your research edition.

Industry ResearchAnti-dementia Drugs Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-dementia Drugs Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Anti-dementia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-dementia Drugs Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-dementia Drugs Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Anti-dementia Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-dementia Drugs include Eisai Inc., Forest Laboratories, Inc, Niksan Pharmaceutical, Pfizer Inc, Reddy's Laboratories, Anhui Taienkang Pharmaceutical Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd. and Jiangsu Hausen Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-dementia Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-dementia Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-dementia Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-dementia Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-dementia Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-dementia Drugs Market by Company

Eisai Inc.

Forest Laboratories, Inc

Niksan Pharmaceutical

Pfizer Inc

Reddy's Laboratories

Anhui Taienkang Pharmaceutical Co., Ltd.

Chengdu Tongde Pharmaceutical Co., Ltd.

Disa Pharmaceutical Group Co., Ltd.

Jiangsu Hausen Pharmaceutical Group Co., Ltd.

Jinri Pharmaceutical (China) Co., Ltd.

Livzon Group Livzon Pharmaceutical Factory

Shandong Luoxin Pharmaceutical Group Co., Ltd.

Shaoxing Jingxin Pharmaceutical Co., Ltd.

Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.

Sichuan Xinston Pharmaceutical Co., Ltd.

Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.

Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.

Yueyang Xinhuada Pharmaceutical Co., Ltd.

Zhejiang Hisun Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Zhejiang Yixin Pharmaceutical Co., Ltd.

Zhien Biotechnology Co., Ltd.

Anti-dementia Drugs Segment by Type

Donepezil

Galantamine

Rivastigmine

Memantine

Other

Anti-dementia Drugs Segment by Application

Clinic

Hospital

Pharmacy

Other

Anti-dementia Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-dementia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-dementia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-dementia Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-dementia Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-dementia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Donepezil Table 2. Major Company of Galantamine Table 3. Major Company of Rivastigmine Table 4. Major Company of Memantine Table 5. Major Company of Other Table 6. Global Anti-dementia Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 8. Global Anti-dementia Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Anti-dementia Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Anti-dementia Drugs Price by Type (2021-2026) & (US$/Unit) Table 12. Global Anti-dementia Drugs Sales by Type (2027-2032) & (K Units) Table 13. Global Anti-dementia Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Anti-dementia Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Anti-dementia Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Anti-dementia Drugs Price by Type (2027-2032) & (US$/Unit) Table 17. North America Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 18. North America Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 20. Europe Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 24. Latin America Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Anti-dementia Drugs Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Anti-dementia Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Anti-dementia Drugs Industry Trends Table 28. Anti-dementia Drugs Industry Drivers Table 29. Anti-dementia Drugs Industry Opportunities and Challenges Table 30. Anti-dementia Drugs Industry Restraints Table 31. Global Anti-dementia Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Anti-dementia Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Anti-dementia Drugs Sales by Company (2021-2026) & (K Units) Table 34. Global Anti-dementia Drugs Sales Share by Company (2021-2026) Table 35. Global Anti-dementia Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Anti-dementia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Anti-dementia Drugs Major Company Production Sites and Headquarters Table 38. Global Anti-dementia Drugs Company, Product Type & Application Table 39. Global Anti-dementia Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Anti-dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Anti-dementia Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Anti-dementia Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Anti-dementia Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Anti-dementia Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Anti-dementia Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Anti-dementia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Anti-dementia Drugs Sales by Region (2027-2032) & (K Units) Table 49. Global Anti-dementia Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Anti-dementia Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Anti-dementia Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Anti-dementia Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Anti-dementia Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 55. Global Anti-dementia Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Anti-dementia Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Anti-dementia Drugs Price by Application (2021-2026) & (US$/Unit) Table 59. Global Anti-dementia Drugs Sales by Application (2027-2032) & (K Units) Table 60. Global Anti-dementia Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Anti-dementia Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Anti-dementia Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Anti-dementia Drugs Price by Application (2027-2032) & (US$/Unit) Table 64. North America Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 65. North America Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 67. Europe Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 71. Latin America Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Anti-dementia Drugs Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Anti-dementia Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Eisai Inc. Company Information Table 75. Eisai Inc. Business Overview Table 76. Eisai Inc. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Eisai Inc. Anti-dementia Drugs Product Portfolio Table 78. Eisai Inc. Recent Development Table 79. Forest Laboratories, Inc Company Information Table 80. Forest Laboratories, Inc Business Overview Table 81. Forest Laboratories, Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Forest Laboratories, Inc Anti-dementia Drugs Product Portfolio Table 83. Forest Laboratories, Inc Recent Development Table 84. Niksan Pharmaceutical Company Information Table 85. Niksan Pharmaceutical Business Overview Table 86. Niksan Pharmaceutical Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Niksan Pharmaceutical Anti-dementia Drugs Product Portfolio Table 88. Niksan Pharmaceutical Recent Development Table 89. Pfizer Inc Company Information Table 90. Pfizer Inc Business Overview Table 91. Pfizer Inc Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Inc Anti-dementia Drugs Product Portfolio Table 93. Pfizer Inc Recent Development Table 94. Reddy's Laboratories Company Information Table 95. Reddy's Laboratories Business Overview Table 96. Reddy's Laboratories Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Reddy's Laboratories Anti-dementia Drugs Product Portfolio Table 98. Reddy's Laboratories Recent Development Table 99. Anhui Taienkang Pharmaceutical Co., Ltd. Company Information Table 100. Anhui Taienkang Pharmaceutical Co., Ltd. Business Overview Table 101. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 103. Anhui Taienkang Pharmaceutical Co., Ltd. Recent Development Table 104. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information Table 105. Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview Table 106. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 108. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Development Table 109. Disa Pharmaceutical Group Co., Ltd. Company Information Table 110. Disa Pharmaceutical Group Co., Ltd. Business Overview Table 111. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio Table 113. Disa Pharmaceutical Group Co., Ltd. Recent Development Table 114. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information Table 115. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview Table 116. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio Table 118. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development Table 119. Jinri Pharmaceutical (China) Co., Ltd. Company Information Table 120. Jinri Pharmaceutical (China) Co., Ltd. Business Overview Table 121. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Portfolio Table 123. Jinri Pharmaceutical (China) Co., Ltd. Recent Development Table 124. Livzon Group Livzon Pharmaceutical Factory Company Information Table 125. Livzon Group Livzon Pharmaceutical Factory Business Overview Table 126. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Portfolio Table 128. Livzon Group Livzon Pharmaceutical Factory Recent Development Table 129. Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information Table 130. Shandong Luoxin Pharmaceutical Group Co., Ltd. Business Overview Table 131. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio Table 133. Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Development Table 134. Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information Table 135. Shaoxing Jingxin Pharmaceutical Co., Ltd. Business Overview Table 136. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 138. Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Development Table 139. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information Table 140. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview Table 141. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 143. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development Table 144. Sichuan Xinston Pharmaceutical Co., Ltd. Company Information Table 145. Sichuan Xinston Pharmaceutical Co., Ltd. Business Overview Table 146. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 148. Sichuan Xinston Pharmaceutical Co., Ltd. Recent Development Table 149. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information Table 150. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Business Overview Table 151. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Portfolio Table 153. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Development Table 154. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information Table 155. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Business Overview Table 156. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 158. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Development Table 159. Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information Table 160. Yueyang Xinhuada Pharmaceutical Co., Ltd. Business Overview Table 161. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 163. Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Development Table 164. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 165. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 166. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 168. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 169. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information Table 170. Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview Table 171. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 173. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Development Table 174. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information Table 175. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview Table 176. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 178. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Development Table 179. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information Table 180. Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview Table 181. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 183. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Development Table 184. Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information Table 185. Zhejiang Yixin Pharmaceutical Co., Ltd. Business Overview Table 186. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 187. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio Table 188. Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Development Table 189. Zhien Biotechnology Co., Ltd. Company Information Table 190. Zhien Biotechnology Co., Ltd. Business Overview Table 191. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 192. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Portfolio Table 193. Zhien Biotechnology Co., Ltd. Recent Development Table 194. North America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 195. North America Anti-dementia Drugs Sales by Country (2021-2026) & (K Units) Table 196. North America Anti-dementia Drugs Sales Market Share by Country (2021-2026) Table 197. North America Anti-dementia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 198. North America Anti-dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 199. North America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. North America Anti-dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 201. North America Anti-dementia Drugs Market Share by Country (2021-2026) Table 202. North America Anti-dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. North America Anti-dementia Drugs Market Share Forecast by Country (2027-2032) Table 204. Europe Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 205. Europe Anti-dementia Drugs Sales by Country (2021-2026) & (K Units) Table 206. Europe Anti-dementia Drugs Sales Market Share by Country (2021-2026) Table 207. Europe Anti-dementia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 208. Europe Anti-dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 209. Europe Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Europe Anti-dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 211. Europe Anti-dementia Drugs Market Share by Country (2021-2026) Table 212. Europe Anti-dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Europe Anti-dementia Drugs Market Share Forecast by Country (2027-2032) Table 214. Asia-Pacific Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 215. Asia-Pacific Anti-dementia Drugs Sales by Country (2021-2026) & (K Units) Table 216. Asia-Pacific Anti-dementia Drugs Sales Market Share by Country (2021-2026) Table 217. Asia-Pacific Anti-dementia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 218. Asia-Pacific Anti-dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 219. Asia-Pacific Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Asia-Pacific Anti-dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 221. Asia-Pacific Anti-dementia Drugs Market Share by Country (2021-2026) Table 222. Asia-Pacific Anti-dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Asia-Pacific Anti-dementia Drugs Market Share Forecast by Country (2027-2032) Table 224. Latin America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 225. Latin America Anti-dementia Drugs Sales by Country (2021-2026) & (K Units) Table 226. Latin America Anti-dementia Drugs Sales Market Share by Country (2021-2026) Table 227. Latin America Anti-dementia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 228. Latin America Anti-dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 229. Latin America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Latin America Anti-dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 231. Latin America Anti-dementia Drugs Market Share by Country (2021-2026) Table 232. Latin America Anti-dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Latin America Anti-dementia Drugs Market Share Forecast by Country (2027-2032) Table 234. Middle East and Africa Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 235. Middle East and Africa Anti-dementia Drugs Sales by Country (2021-2026) & (K Units) Table 236. Middle East and Africa Anti-dementia Drugs Sales Market Share by Country (2021-2026) Table 237. Middle East and Africa Anti-dementia Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 238. Middle East and Africa Anti-dementia Drugs Sales Market Share Forecast by Country (2027-2032) Table 239. Middle East and Africa Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 240. Middle East and Africa Anti-dementia Drugs Market Size by Country (2021-2026) & (US$ Million) Table 241. Middle East and Africa Anti-dementia Drugs Market Share by Country (2021-2026) Table 242. Middle East and Africa Anti-dementia Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 243. Middle East and Africa Anti-dementia Drugs Market Share Forecast by Country (2027-2032) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Anti-dementia Drugs Distributors List Table 247. Anti-dementia Drugs Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Anti-dementia Drugs Image Figure 2. Global Anti-dementia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-dementia Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-dementia Drugs Sales (2021-2032) & (K Units) Figure 5. Donepezil Image Figure 6. Global Donepezil Sales YoY Growth (2021-2032) & (K Units) Figure 7. Galantamine Image Figure 8. Global Galantamine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Rivastigmine Image Figure 10. Global Rivastigmine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Memantine Image Figure 12. Global Memantine Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Anti-dementia Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Anti-dementia Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Anti-dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Anti-dementia Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Anti-dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Anti-dementia Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Anti-dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Anti-dementia Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Anti-dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Anti-dementia Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Anti-dementia Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Anti-dementia Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Anti-dementia Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Pharmacy Image Figure 34. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Anti-dementia Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Anti-dementia Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Anti-dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Anti-dementia Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Anti-dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Anti-dementia Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Anti-dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Anti-dementia Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Anti-dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Anti-dementia Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Anti-dementia Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Anti-dementia Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Anti-dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Anti-dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Anti-dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Anti-dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti-dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Anti-dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Anti-dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Anti-dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti-dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Anti-dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Anti-dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Anti-dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti-dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Anti-dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Anti-dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Anti-dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti-dementia Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Anti-dementia Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Anti-dementia Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Anti-dementia Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Anti-dementia Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Anti-dementia Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Donepezil
  • Galantamine
  • Rivastigmine
  • Memantine
  • Other
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Eisai Inc.
  • Forest Laboratories, Inc
  • Niksan Pharmaceutical
  • Pfizer Inc
  • Reddy's Laboratories
  • Anhui Taienkang Pharmaceutical Co., Ltd.
  • Chengdu Tongde Pharmaceutical Co., Ltd.
  • Disa Pharmaceutical Group Co., Ltd.
  • Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  • Jinri Pharmaceutical (China) Co., Ltd.
  • Livzon Group Livzon Pharmaceutical Factory
  • Shandong Luoxin Pharmaceutical Group Co., Ltd.
  • Shaoxing Jingxin Pharmaceutical Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  • Sichuan Xinston Pharmaceutical Co., Ltd.
  • Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
  • Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
  • Yueyang Xinhuada Pharmaceutical Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Huahai Pharmaceutical Co., Ltd.
  • Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • Zhejiang Yixin Pharmaceutical Co., Ltd.
  • Zhien Biotechnology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-dementia Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-dementia Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-dementia Drugs Market by Type
  6. 1.3.1 Donepezil
  7. 1.3.2 Galantamine
  8. 1.3.3 Rivastigmine
  9. 1.3.4 Memantine
  10. 1.3.5 Other
  11. 1.4 Global Anti-dementia Drugs Market Size by Type
  12. 1.4.1 Global Anti-dementia Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Anti-dementia Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Anti-dementia Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Anti-dementia Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Anti-dementia Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Anti-dementia Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Anti-dementia Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Anti-dementia Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-dementia Drugs Industry Trends
  2. 2.2 Anti-dementia Drugs Industry Drivers
  3. 2.3 Anti-dementia Drugs Industry Opportunities and Challenges
  4. 2.4 Anti-dementia Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-dementia Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-dementia Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-dementia Drugs Price (2021-2026)
  4. 3.4 Global Anti-dementia Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-dementia Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-dementia Drugs Company, Product Type & Application
  7. 3.7 Global Anti-dementia Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-dementia Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-dementia Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-dementia Drugs Tier 1, Tier 2, and Tier 3
4 Anti-dementia Drugs Regional Status and Outlook
  1. 4.1 Global Anti-dementia Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-dementia Drugs Historic Market Size by Region
  3. 4.2.1 Global Anti-dementia Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-dementia Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-dementia Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-dementia Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Anti-dementia Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-dementia Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-dementia Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-dementia Drugs by Application
  1. 5.1 Anti-dementia Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Other
  6. 5.2 Global Anti-dementia Drugs Market Size by Application
  7. 5.2.1 Global Anti-dementia Drugs Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-dementia Drugs Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-dementia Drugs Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-dementia Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-dementia Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-dementia Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-dementia Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-dementia Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai Inc.
  2. 6.1.1 Eisai Inc. Company Information
  3. 6.1.2 Eisai Inc. Business Overview
  4. 6.1.3 Eisai Inc. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Inc. Anti-dementia Drugs Product Portfolio
  6. 6.1.5 Eisai Inc. Recent Developments
  7. 6.2 Forest Laboratories, Inc
  8. 6.2.1 Forest Laboratories, Inc Company Information
  9. 6.2.2 Forest Laboratories, Inc Business Overview
  10. 6.2.3 Forest Laboratories, Inc Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Forest Laboratories, Inc Anti-dementia Drugs Product Portfolio
  12. 6.2.5 Forest Laboratories, Inc Recent Developments
  13. 6.3 Niksan Pharmaceutical
  14. 6.3.1 Niksan Pharmaceutical Company Information
  15. 6.3.2 Niksan Pharmaceutical Business Overview
  16. 6.3.3 Niksan Pharmaceutical Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Niksan Pharmaceutical Anti-dementia Drugs Product Portfolio
  18. 6.3.5 Niksan Pharmaceutical Recent Developments
  19. 6.4 Pfizer Inc
  20. 6.4.1 Pfizer Inc Company Information
  21. 6.4.2 Pfizer Inc Business Overview
  22. 6.4.3 Pfizer Inc Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc Anti-dementia Drugs Product Portfolio
  24. 6.4.5 Pfizer Inc Recent Developments
  25. 6.5 Reddy's Laboratories
  26. 6.5.1 Reddy's Laboratories Company Information
  27. 6.5.2 Reddy's Laboratories Business Overview
  28. 6.5.3 Reddy's Laboratories Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Reddy's Laboratories Anti-dementia Drugs Product Portfolio
  30. 6.5.5 Reddy's Laboratories Recent Developments
  31. 6.6 Anhui Taienkang Pharmaceutical Co., Ltd.
  32. 6.6.1 Anhui Taienkang Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Anhui Taienkang Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  36. 6.6.5 Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Chengdu Tongde Pharmaceutical Co., Ltd.
  38. 6.7.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  42. 6.7.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Disa Pharmaceutical Group Co., Ltd.
  44. 6.8.1 Disa Pharmaceutical Group Co., Ltd. Company Information
  45. 6.8.2 Disa Pharmaceutical Group Co., Ltd. Business Overview
  46. 6.8.3 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
  48. 6.8.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments
  49. 6.9 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
  50. 6.9.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
  51. 6.9.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
  52. 6.9.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
  54. 6.9.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
  55. 6.10 Jinri Pharmaceutical (China) Co., Ltd.
  56. 6.10.1 Jinri Pharmaceutical (China) Co., Ltd. Company Information
  57. 6.10.2 Jinri Pharmaceutical (China) Co., Ltd. Business Overview
  58. 6.10.3 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Portfolio
  60. 6.10.5 Jinri Pharmaceutical (China) Co., Ltd. Recent Developments
  61. 6.11 Livzon Group Livzon Pharmaceutical Factory
  62. 6.11.1 Livzon Group Livzon Pharmaceutical Factory Company Information
  63. 6.11.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
  64. 6.11.3 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Portfolio
  66. 6.11.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
  67. 6.12 Shandong Luoxin Pharmaceutical Group Co., Ltd.
  68. 6.12.1 Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information
  69. 6.12.2 Shandong Luoxin Pharmaceutical Group Co., Ltd. Business Overview
  70. 6.12.3 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
  72. 6.12.5 Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments
  73. 6.13 Shaoxing Jingxin Pharmaceutical Co., Ltd.
  74. 6.13.1 Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Shaoxing Jingxin Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  78. 6.13.5 Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
  80. 6.14.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  84. 6.14.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 Sichuan Xinston Pharmaceutical Co., Ltd.
  86. 6.15.1 Sichuan Xinston Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 Sichuan Xinston Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  90. 6.15.5 Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
  92. 6.16.1 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information
  93. 6.16.2 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Business Overview
  94. 6.16.3 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Portfolio
  96. 6.16.5 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments
  97. 6.17 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
  98. 6.17.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  102. 6.17.5 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Yueyang Xinhuada Pharmaceutical Co., Ltd.
  104. 6.18.1 Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Yueyang Xinhuada Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  108. 6.18.5 Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Zhejiang Hisun Pharmaceutical Co., Ltd.
  110. 6.19.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  114. 6.19.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Zhejiang Huahai Pharmaceutical Co., Ltd.
  116. 6.20.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
  117. 6.20.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview
  118. 6.20.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  120. 6.20.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments
  121. 6.21 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
  122. 6.21.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information
  123. 6.21.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview
  124. 6.21.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  126. 6.21.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
  127. 6.22 Zhejiang Jingxin Pharmaceutical Co., Ltd.
  128. 6.22.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
  129. 6.22.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
  130. 6.22.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  132. 6.22.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
  133. 6.23 Zhejiang Yixin Pharmaceutical Co., Ltd.
  134. 6.23.1 Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information
  135. 6.23.2 Zhejiang Yixin Pharmaceutical Co., Ltd. Business Overview
  136. 6.23.3 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
  138. 6.23.5 Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments
  139. 6.24 Zhien Biotechnology Co., Ltd.
  140. 6.24.1 Zhien Biotechnology Co., Ltd. Company Information
  141. 6.24.2 Zhien Biotechnology Co., Ltd. Business Overview
  142. 6.24.3 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Portfolio
  144. 6.24.5 Zhien Biotechnology Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Anti-dementia Drugs Sales by Country
  2. 7.1.1 North America Anti-dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-dementia Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-dementia Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-dementia Drugs Market Size by Country
  6. 7.2.1 North America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-dementia Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-dementia Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-dementia Drugs Sales by Country
  2. 8.1.1 Europe Anti-dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-dementia Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-dementia Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-dementia Drugs Market Size by Country
  6. 8.2.1 Europe Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-dementia Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-dementia Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-dementia Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Anti-dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-dementia Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-dementia Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-dementia Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-dementia Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-dementia Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-dementia Drugs Sales by Country
  2. 10.1.1 South America Anti-dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-dementia Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-dementia Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-dementia Drugs Market Size by Country
  6. 10.2.1 South America Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-dementia Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-dementia Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-dementia Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Anti-dementia Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-dementia Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-dementia Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-dementia Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-dementia Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-dementia Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-dementia Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-dementia Drugs Value Chain Analysis
  2. 12.1.1 Anti-dementia Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-dementia Drugs Production Mode & Process
  7. 12.2 Anti-dementia Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-dementia Drugs Distributors
  10. 12.2.3 Anti-dementia Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst